Beruflich Dokumente
Kultur Dokumente
antibiotic resistance
Contents
Foreword................................................................................................................................3
Swedish strategy to combat antibiotic resistance...............................................5
Objective 1: Increased knowledge through enhanced surveillance ......................7
Objective 2: Continuous strong preventive measures...............................................8
Objective 3: Responsible use of antibiotics................................................................ 10
Objective 4: Increased knowledge for preventing and managing bacterial
infections and antibiotic resistance with new methods.................. 12
Objective 5: Improved awareness and understanding in society
about antibiotic resistance and countermeasures.......................... 14
Objective 6: Supporting structures and systems..................................................... 16
Objective 7: L
eadership within the EU and at
the international cooperation................................................................. 17
Past and present work in Sweden............................................................................ 20
Photo:
Jessica Gow/TT (cover),
Jessica Gow/TT (p 4, 13, 15)
Maskot/Folio (p 9),
John Sandlund/Folio (p 23).
Antibiotic-resistant bacteria are spread globally in the same way as This strategy is to form the basis of
other bacteria. This means they can be transferred between people, Sweden’s work to curb the develop-
animals and foodstuffs, and they can spread in our environment. ment and spread of antibiotic resis-
These links between the various sectors mean that efforts to combat tance and to deal with the situation
antibiotic resistance must be made from a broad perspective. we have today. The strategy is to high-
light areas and measures for effective
This is called a One Health approach. It is important that the term work to combat antibiotic resistance.
One Health is understood in a way that all significant factors must be Sweden’s work to combat antibiotic
covered, such as issues concerning the economy, education, research resistance must be long-term and sus-
and aid, in order to deal globally with the problems of resistance. tainable, and it must build on the good
international reputation Sweden has
Health care environments are particularly at risk for the emergence in this area.
and spread of antibiotic resistance. Infections caused by resistant
bacteria can have serious consequences, such as increased mortality The strategy, which covers work at the
and prolonged illnesses, and a reduced ability to protect patients national level, as well as within the
using antibiotics during a surgery and other medical procedures. EU and at the international level,
This results in suffering for patients and increased costs for health applies until 2020.
and medical care services, and the society as a whole.
The global commitments made
In addition, currently established treatment methods for diseases within the 2030 Agenda, as well as
such as cancer, as well as some areas of transplant surgery and other Sweden’s Policy for Global Develop-
advanced surgery, may need to be re-evaluated. This may, in time, ment, are key frameworks for
also apply to more common surgical procedures, such as prosthetics. Sweden’s continued leadership in
the international work.
In animal populations, resistant bacteria can spread quickly and
thus represent a reservoir of bacteria that can spread further to both The strategy is based on Sweden’s
people and animals. Animals can also get infections that are difficult current work to combat antibiotic
to treat as a result of resistant bacteria. This causes suffering for the resistance, the Global action plan
animals and economic losses. on antimicrobial resistance that was
adopted by WHO member states at
Important functions in society can also be affected by growing the World Health Assembly in May
antibiotic resistance. 2015, confirmed by FAO and OIE
resolutions, and relevant documenta-
tion, such as evaluations, action plans
and other strategies.
It is necessary to continuously collect ence how well treatment recommen- • possibilities to systematically moni-
data on the occurrence of resistant dations are used by prescribers (e.g. tor the long-term trends concerning
bacteria and use of antibiotics. This doctors and veterinarians). We have resistance, sales and use of antibio-
enables us to analyse trends over a long tradition in Sweden and high tics, and human and animal infec-
time, see important changes that level of expertise in surveillance, but tions to be maintained and further
could indicate a spread of resistant the systems used need to be improved developed;
bacteria, quickly detect such a spread, and further developed to become more
communicate findings and take mea- effective and efficient, and to be adap- • data about the reasons for prescrip-
sures at an early stage. Surveillance ted to new challenges. tion and compliance with treatment
also makes it possible for us to moni- recommendations to be available
tor the effects of measures taken and The Government expects: in all sectors and the results fed
to evaluate them. • appropriate data to be collected back into relevant services.
from relevant sectors and fed back
Using comparable resistance data from where relevant at local, regional
various sectors, we can map out path- and national level, as well as at EU
ways of spread and the significance of and international level;
different sources for the resistance
problem. It is also important to be able • efficient systems for early detection,
to link an antibiotic prescription to a compilation, analysis and reporting
diagnosis so as to monitor and influ- of information to be in place;
90 n Sweden
n Denmark
80 n Netherlands
n Spain
n Germany
70
The favourable resistance situation use and partly because of the spread
in Sweden does not mean we can be of bacteria to patients more suscepti- An important success
complacent. Resistance is growing ble to infections. This, in turn, means factor for effective natio-
here as well, albeit more slowly than a greater risk of serious complications nal work against antibiotic
elsewhere. We must remain vigilant for these patients.
resistance has been close
and realise the importance of preven-
tive measures so that the situation The need for antibiotics in animals cooperation between the
does not deteriorate. Infection preven- is reduced through efficient disease local and national levels
tion measures will reduce the need for control, good farm management, in the health care sector,
antibiotics. People and animals that biosecurity, and sound animal hus- and also between central
are healthy or that receive good treat- bandry systems. Safe international government and the live-
ment or care will be less in need of trade in both living animals and stock industry.
antibiotics. animal products is particularly impor-
tant. This also reduces the risk of
The national vaccination programmes resistant bacteria spreading to other
and measures to maintain good hygie- animals, to foodstuffs and to people.
nic standards in health care settings
are fundamental as infection preven- Releasing antibiotics and other anti-
tion measures. Healthcare-associated bacterial agents into the environment
infections are the most common can give rise to resistance. Although
adverse event in health care settings, our knowledge about how antibiotics
and a number of these infections are and other antibacterial agents can
caused by bacteria that have acquired select for antibiotic-resistant bacteria
various resistance mechanisms. in the environment is incomplete,
Health care settings are particularly there is data to indicate that this is an
sensitive for the development and important factor.
spread of antibiotic resistance, partly
because of the high level of antibiotic
Figure 2. Sales of veterinary antimicrobial agents for food-producing animals in the EU. Expressed as mg of
active substance per Population Correction Unit (PCU). PCU corresponds to the total weight of live animals
within a country, expressed in kilograms. The measure is not exact and should therefore be interpreted with
caution. Source: Fifth ESVAC report 2013, European Medicines Agency.
One contributing factor to the serious- biotic resistance for the health sector.
ness of the resistance problem is that The effects of actions taken must be Antimicrobial resistance
the development of new antibiotics measurable as well as the economic refers to resistance among
and other treatment options has slow- consequences of resistance. The costs bacteria, viruses and other
ed down. This is due to several fac- and benefits of antibiotic use and resis-
microorganisms, whereas
tors, including low profitability, but tance in animal production must be
also the scientific difficulty of finding possible to estimate to justify further antibacterial resistance
new approaches. To enable the deve- improvements at national and inter- (antibiotic resistance) ref-
lopment of new treatment strategies national levels. Increased knowledge ers only to resistance in
and preventive measures, research is is also needed about how the structure bacteria.
necessary into how bacteria give rise of health and medical care systems,
to infections and what other factors animal production, global trade and
affect which individuals are infected tourism affects the spread of antimi-
and how severely they are affected. crobial resistance between bacteria,
Equally, research is needed to be able people, animals and the environment.
to optimise and preserve the efficacy
of existing treatments for as long as These challenges cannot be solved
possible. The development of cost- by individual nations; they require
effective methods for better infection coordinated international cooperation
diagnostics and sensitivity tests could spanning many sectors. The EU is an
reduce the incorrect use of antibiotics important platform for the work to
in health care, veterinary medicine be carried out by Sweden.
and animal husbandry.
The basic idea behind the Swedish Today there is a strong consensus Sweden is a result of regulated sales
work against antibiotic resistance is amongst the country’s animal health of antibiotics both on the animal and
that an overall low infection rate in organizations, veterinary personnel the human side, and sound surveil-
the society leads to a healthy popula- and professional animal keepers on lance of the prescription of antibiotics.
tion and healthy animals with lesser restrictive and responsible antibiotic Treatment recommendations for
need of antibiotics. This in turn leads use. Sweden has a long tradition of infections, both the within health
to a reduced selection of resistant bac- preventive work to keep the animals care and dental care, are produced
teria. Prevention control practices healthy, and healthy animals need and updated by the Medical Products
may include anything from vaccina- little antibiotics. Agency and the Public Health Agency.
tions, good diagnostics, good hygiene, Corresponding work regarding vet-
active animal health work and good We carry out continuous resistance erinary medicine has been performed
animal husbandry, to public health surveillance in Sweden and are well for the major domestic animal species
interventions against lifestyle diseases informed about the current resistance by the Medical Products Agency and
directed towards the profession as situation. Samples are often collected by the Swedish Veterinary Associa-
well as the general public. from patients within the health care tion. Furthermore, the Swedish Board
system which provides us with data of Agriculture has adopted regulations
Significant attention has been paid, at for surveillance. Sweden has also in- on antibiotics that should not be given
an early stage, to antibiotic resistance vested in well-functioning standardi- to animals.
in Sweden, and measures were taken zed laboratories. The systems for sur-
to prevent the spread of resistant bac- veillance of antibiotic resistance are In order to further support optimized
teria and to limit the unnecessary use based on voluntary participation of use of antibiotics through surveillance,
of antibiotics. Due to close collabora- laboratories complementing the not- analysis and feedback on compliance
tion between government agencies ifications made in accordance with to treatment recommendations, data
and interested parties representing the Communicable Diseases Act. is needed that links prescription with
animal husbandry, Sweden was the The Public Health Agency analyses, diagnosis.
first country within the European compiles and provides feedback of
Union to prohibit antibiotic additives national data of antibiotic resistance Antibiotic resistance has been a prio-
as growth promoters in animal feed- and antibiotic use, and the incidence ritised research topic in Sweden for
stuff. This was already in place 1986. of health care associated infections. many years. The latest research and
innovation government bill included
The favourable situation, from an Sweden also has a programme for a focus on antibiotics and infection,
international perspective, as regards monitoring of antibiotic resistant bac- resulting in graduate schools and re-
antibiotic resistance in humans and teria in food producing animals and search grants within this area. Sweden
animals is a result of early awareness food. The Swedish National Veteri- was also – along with Italy – the initi-
of the problem. One example is the nary Institute is responsible for this ator of the international research col-
low prevalence of methicillin resistant monitoring, regarding food this work laboration that was initiated in the
Staphylococcus aureus (MRSA) (see is conducted in collaboration with the field of antibiotic resistance in 2010,
figure 3, page 21). Also, this bacteri- National Food Agency. Through Joint Programming Initiative on
um has yet not become established in yearly surveillance of antibiotic resi- Antimicrobial Resistance. Today the
our Swedish pig population. From an dues in meat, samples are taken in collaboration includes 22 countries,
international perspective, Sweden has order to ensure that animals used for of which several are non-European.
a relatively low use of antibiotics per food production will not be treated Sweden had the presidency for the
capita (see figure 4, page 22). Pres- with antibiotics prior to slaughter. first six years and the secretariat is
cription of antibiotics has decreased located at the Swedish Research Coun-
since the middle of the 1990s, we have The results from the surveillance cil. JPIAMR has developed a strategic
seen a total decline with over 40 per- of resistance and antibiotic use in research agenda, which has formed
cent. For animals the use of antibio- humans and animals are presented the basis for several countries’ national
tics is the lowest within the EU. The annually in a joint report by the agendas.
total amount of antibiotics given to ani- Swedish National Veterinary Institute
mals in Sweden has decreased by 60 and the Public Health Agency.
percent since the middle of the 1980s. The relatively good situation in
35
30
DDD per 1000 inhabitants and per day
25
20
15
10
0
ce nia* nce ium Italy rus urg alta land land pain atia aria akia om ugal land blic land gary ania way ark any enia stria den tvia onia nds
ee a g p o M re S Cro ulg lov ingd ort Ice epu Fin un thu Nor enm erm lov Au we La Est erla
Gr oma Fr Bel Cy emb I Po B S K P H Li S S
R x d hR D G
Ne
th
L u ite ec
Un Cz